Alpha International Communication LLC
トップへ

Japanese Medical Products for International Clinics

Japan-sourced product information
for clinical evaluation worldwide.

For physicians, clinics and medical distributors seeking Japanese medical products, AIC supports product information, documentation review and international supply discussions for Pure Stem-related products.

Request product informationExplore products

Japan Medical Product Consultation

Understand the product.
Evaluate the evidence.

For a medical product assessment, a product name is only a starting point. Review biological source, manufacturing process, analytical method, lot specifications, handling and storage. AIC separates information published by the manufacturer from the documents that must be confirmed for a specific product and lot.

How to assess product differences

Pure Stem’s public materials highlight cytokines, growth factors, source-specific products and manufacturing processes. These details can help characterize a product; they do not by themselves establish clinical efficacy or safety. Review source, assay method, product specification and lot documentation, and distinguish basic research, manufacturer information and clinical evidence.

Scientific context

Cytokines are proteins involved in cell-to-cell signaling; growth factors are associated with processes such as cell growth and differentiation. Exosomes are a type of extracellular vesicle, and NMN is studied as a precursor involved in NAD⁺ biosynthesis. These biological descriptions do not demonstrate a therapeutic effect for an individual product.

International supply & export coordination

Japanese products.
International clinical perspective.

AIC has supported international product discussions across the Philippines and other markets, and is familiar with the practical coordination required for export processing. We help international buyers structure the questions that matter: destination, shipping conditions, available product documentation, labeling considerations and the next professional review.

  • International inquiry coordination across the Philippines and other markets
  • Export-processing and cross-border supply discussions
  • Destination-focused documentation and handling review
  • Clear communication for physicians, clinics and medical distributors
Import clearance, product registration, advertising, distribution and clinical use are subject to the laws and requirements of the destination country. These are confirmed independently for every case.

Japanese Product Information

Products, ingredients
and review points

Explore manufacturer-sourced information on stem cell conditioned medium FD, umbilical cord blood-derived exosomes and NMN. Product specifications, analytical data and availability must be confirmed against current documentation.

01

Adipose- and dental pulp-derived | Freeze-dried

Human Stem Cell Conditioned Medium FD Rich

Stem cell conditioned medium is the cell-free medium collected after cell culture. Pure Stem’s manufacturer information focuses on cytokines and growth factors and lists adipose- and dental pulp-derived options. Cytokines are signaling proteins involved in cell-to-cell communication; growth factors are associated with processes such as cell growth and differentiation. Measuring their content can help characterize a product, but does not by itself establish clinical efficacy.

  • Sources listed on the manufacturer site: adipose and dental pulp
  • The manufacturer describes serum-free culture, no antibiotics or preservatives, and a process without frozen cells
  • Batch-level cytokine content measurement is described by the manufacturer
  • CPC, clean-room and filtration information is published; the manufacturer’s home page describes the CPC as Class 100
  • A proprietary freeze-drying process and reconstitution are described. The site also mentions ambient management up to 40°C; confirm current product-specific storage instructions
Review source, specifications, assay methods, lot data, storage and reconstitution conditions before evaluation.
02

Umbilical cord blood-derived | Freeze-dried

Umbilical Cord Blood-Derived Exosomes

Exosomes are a type of extracellular vesicle studied in cell communication. Pure Stem’s public product page describes an umbilical cord blood-derived product and presents related growth-factor and cytokine information. Profiles vary with source, manufacturing and analytical methods. A medical evaluation should distinguish a proposed biological role from evidence of a clinical outcome in humans.

  • Source listed on the manufacturer site: umbilical cord blood
  • Presented as a freeze-dried product
  • Manufacturer-published information discusses growth factors and cytokines
  • Confirm individual components, amounts, particle characteristics and test methods in lot-specific documents
Manufacturer statements and research hypotheses are not equivalent to demonstrated efficacy or safety in patients.
03

NMN | Professional product information

Pure Stem NMN 300 mg

NMN (nicotinamide mononucleotide) is studied as a precursor involved in NAD⁺ biosynthesis. Pure Stem’s public page explains the NMN–NAD relationship and states that purity is supported by a third-party product specification document. AIC’s listed 300 mg freeze-dried specification should be checked against the latest product specification before adoption.

  • Manufacturer information introduces the relationship between NMN and NAD⁺ metabolism
  • AIC product material lists 300 mg NMN and a freeze-dried format
  • The manufacturer describes third-party product-specification documentation for purity
  • Confirm ingredient specification, assay method, amount per unit and storage conditions
General research on a compound does not establish clinical efficacy or an indication for a specific product.
04

Japan-made NMN supplement information

Pure Stem NMN15000

AIC product material lists a 90-capsule format containing 15,000 mg of β-NMN per bottle. For an international medical or distribution inquiry, review the current product label, serving information, raw-material specification and purity documentation together with the rules in the destination market.

  • 15,000 mg β-NMN per bottle (AIC product material)
  • 90 capsules (AIC product material)
  • Review current label, serving information and analytical documentation
Supplement information only; this is not a statement of medicinal efficacy or treatment use.
05

Cosmetic information

Exosome Skin Repair Cream 40

AIC product materials describe a 30 g skincare product. Review the current ingredient list, cosmetic classification, label and directions for use. Manufacturer material also introduces a liposome-based formulation approach.

  • 30 g format (AIC product material)
  • Review full ingredient list and cosmetic labeling
  • Manufacturer material describes a liposome-based formulation
Cosmetic information only; do not infer medicinal effects.
06

Professional product information

Pure Stem Nasal Kit

AIC-held manufacturer materials describe a kit with freeze-dried material, solution and container. Confirm selected material, preparation procedure, use-by period, storage after reconstitution and product classification using current kit-specific documentation.

  • Confirm kit contents and selectable materials in current product documents
  • Review preparation, use-by period and storage requirements
  • Confirm intended use and professional handling requirements
Do not determine use or suitability from this page alone; consult current manufacturer documents and qualified professionals.
07

Medical-collaboration product information

High-Dose Vitamin C (12.5 g / 25 g)

Freeze-dried products in 12.5 g and 25 g formats. Information is organized for medical collaboration where a physician’s assessment and clinical suitability review are prerequisites.

  • 12.5 g / 25 g product formats
  • Freeze-dried (FD) format
  • Physician assessment and suitability review required
No individual treatment effect or safety outcome is guaranteed.

Manufacturer product pages

Stem Cell Conditioned Medium FD ↗Umbilical Cord Blood-Derived Exosome ↗NMN ↗These links identify the manufacturer’s public product descriptions; they are not independent verification of claims or comparative statements.
A clinic product-information evaluation setting
Source, product profile and supply conditions are organized around your evaluation context.
Reviewing quality-related documentation
Quality-related documentation and handling conditions are reviewed together.

Medical Product Evaluation

Four review dimensions
before adoption

Keep product characteristics separate from clinical outcomes. Match each statement to its source, method, scope and product lot.

01

Ingredient & source

Confirm biological source, named components, reported amounts, units and lot variation.

02

Manufacturing & quality

Review culture and processing information, analytical methods, specifications and quality-control documents.

03

Clinical evidence

Distinguish basic research, manufacturer statements and clinical studies; assess populations, endpoints and limitations.

04

Handling & workflow

Confirm intended use, storage, preparation, use period and supply conditions in current product documents.

Specifications or test conditions not available in public sources are not inferred. We can identify the documents to request for a product and lot.

Consultation Process

A practical review process

  1. 01

    Initial inquiry

    Tell us about your organization, specialty, intended use and destination.

  2. 02

    Information review

    We clarify the product information and documentation needed for your evaluation.

  3. 03

    Supply discussion

    Destination, availability and relevant requirements are reviewed case by case.

  4. 04

    Next-step guidance

    Where appropriate, we guide you through the next required discussion or process.

International Review

Japan-sourced information,
reviewed for your destination.

Japan-to-world medical information and supply consultation
We begin with the information and destination-specific questions your organization needs to review.

Important Notice

Professional product information

This page provides general product information for medical professionals. Manufacturer descriptions of product features or research background do not establish the efficacy or safety of a product for diagnosis, treatment or prevention. Product classification, intended use, advertising, import, distribution and clinical handling requirements vary by product and jurisdiction. Review current product documents, available evidence, applicable requirements and qualified professional guidance before adoption. AIC does not present the information on this page as a guarantee of clinical outcomes.

International Medical Inquiries

Request information or a consultation

Please include your organization, country or region, product of interest and intended use.

Email AIC in EnglishContact form